logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hidenori Toyoda

ogaki municipal hospital
H指数:75
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

WFUMB-Recommended Versus Manufacturer-Optimized Protocols for Ultrasound-Guided Attenuation Parameter in Hepatic Steatosis Assessment: A Retrospective Single-Vendor Multicenter Study

WFUMB推荐与制造商优化协议在超声引导衰减参数评估肝脂肪变中的比较：一项回顾性单一供应商多中心研究

Journal of Clinical Medicine
IF2.9
2026-10-280
OA
Hidekatsu Kuroda; Takuma Oguri; Naohisa Kamiyama; Hidenori Toyoda; Satoshi Yasuda; Kento Imajo; Yasuaki Suzuki; Katsutoshi Sugimoto; Tomoyuki Akita; Takashi Kumada
A Novel Decentralized Rapid Test for Detection of Hepatitis C virus Antigens Using Smart Polymer Technology: A Prospective Multinational Study

利用智能聚合物技术的新型去中心化快速检测丙型肝炎病毒抗原的方法：一项前瞻性跨国研究

The Journal of Infectious Diseases
IF0
2026-09-170
PRE
Gamal Shiha; Mitsuhiro Ebara; Ayman Hassan; Hidenori Toyoda; Mohamed Abdel-Samiee; Yosra Osama Khalifa; Hossam A Galbt; Eman Abdelsameea; Ahmed Farahat; Dina H Ziada; Madonna Magdy Fahmy; Asad Ali Choudhry; Auj Chaudhry; Hafsa Asad; Ahmed Nabil; Gaston Picchio; Riham Soliman
IgA-Enriched Phenotype Predicts Liver-Related Events in MASLD

IgA富集表型可预测MASLD相关的肝脏事件

Journal of Hepatology
IF33
2026-07-150
PRE
Takefumi Kimura; Shun-ichi Wakabayashi; Takanobu Iwadare; Shohei Kondo; Taiki Okumura; Hiroyuki Kobayashi; Yuki Yamashita; Yuma Kamijo; Kaede Fujita; Tomoyuki Nakajima; Takuro Uchida; Tomoo Yamazaki; Mai Iwaya; Takeshi Uehara; Hidenori Toyoda; Takashi Kumada; Takeji Umemura; Naoki Tanaka
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions

全球不同地理区域真实世界随访中预测SVR后HCC风险模型的验证

Liver International
IF5.2
2026-06-080
OA
Hidenori Toyoda; Yujin Hoshida; Neehar D. Parikh; Prasun K. Jalal; Federico Piñero; Manuel Mendizabal; Ezequiel Ridruejo; Hugo Cheinquer; Andrea Casadei-Gardini; Mounika Kanneganti; Arndt Weinmann; Markus Peck-Radosavljevic; Jean-Francois Dufour; Pompilia Radu; Gamal Shiha; Riham Soliman; Shiv K. Sarin; Manoj Kumar; Jing-Houng Wang; Pisit Tangkijvanich; Wattana Sukeepaisarnjaroen; Masanori Atsukawa; Haruki Uojima; Akito Nozaki; Makoto Nakamuta; Koichi Takaguchi; Atsushi Hiraoka; Hiroshi Abe; Kentaro Matsuura; Tsunamasa Watanabe; Noritomo Shimada; Kunihiko Tsuji; Toru Ishikawa; Shigeru Mikami; Ei Itobayashi; Philip J. Johnson; Amit G. Singal
Ablation-Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma

在初始使用阿替利珠单抗/贝伐珠单抗控制疾病后，疾病进展时基于消融的挽救策略在肝细胞癌中的应用

Hepatology Research
IF3.4
2026-05-110
PRE
Kazuya Kariyama; Kazuhiro Nouso; Atsushi Hiraoka; Fujimasa Tada; Hideko Ohama; Hidenori Toyoda; Satoshi Yasuda; Toshifumi Tada; Kazunari Tanaka; Kunihiko Tsuji; Ei Itobayashi; Akemi Tsutsui; Koichi Takaguchi; Michitaka Imai; Toru Ishikawa; Takeshi Hatanaka; Yuki Kanayama; Satoru Kakizaki; Atsushi Naganuma; Yoshihide Ueda; Tomomitsu Matono; Hideyuki Tamai; Junpei Okamura; Hironori Tanaka; Yutaka Yata; Akiko Wakuta; Masatoshi Kudo; Takashi Kumada
Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score-Matched Study Using Linear Mixed-Effects Models

与恩替卡韦相比，替诺福韦艾拉酚胺在降低乙型肝炎表面抗原方面的卓越疗效：一项使用线性混合效应模型的多中心倾向性评分匹配研究

ALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
2026-05-040
PRE
Takashi Kumada; Masanori Atsukawa; Norio Itokawa; Taeang Arai; Hidenori Toyoda; Akihito Tsubota; Tsunamasa Watanabe; Makoto Chuma; Kentaro Matsuura; Atsushi Hiraoka; Toshifumi Tada; Koichi Takaguchi; Keizo Kato; Hiroshi Abe; Joji Tani; Toru Ishikawa; Chikara Ogawa; Toru Asano; Tsunekazu Oikawa; Yoshihiro Matsumoto; Tomoyuki Akita; Junko Tanaka
Diagnostic Impact of Two-Dimensional Shear Wave Elastography for Liver Fibrosis: A Multicenter Retrospective Study

二维剪切波弹性成像对肝纤维化的诊断影响：一项多中心回顾性研究

Hepatology Research
IF3.4
2026-05-010
OAAI
Takashi Nishimura; Toshifumi Tada; Yasuaki Suzuki; Kento Imajo; Katsutoshi Sugimoto; Sadanobu Ogawa; Hidenori Toyoda; Tamami Abe; Hidekatsu Kuroda; Masashi Hirooka; Asako Nogami; Satoshi Oeda; Hirokazu Takahashi; Tomoyuki Akita; Reiichiro Kondo; Takuma Nakatsuka; Ryosuke Tateishi; Yoichi Hiasa; Yuichiro Eguchi; Atsushi Nakajima; Hirohisa Yano; Shigehiro Kokubu; Junko Tanaka; Fuminori Moriyasu; Masayoshi Kage; Takashi Kumada; Hiroko Iijima
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

不可切除性肝细胞癌接受阿替利珠单抗联合贝伐珠单抗治疗后出血事件的临床特征、预测因素及抗血栓治疗的影响

Hepatology Research
IF3.4
2026-04-210
PRE
Fujimasa Tada; Atsushi Hiraoka; Hideko Ohama; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) Group
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab

肝内肿瘤负荷对接受阿替利珠单抗联合贝伐珠单抗治疗的合并肝外转移的肝细胞癌患者预后的影响

Hepatology Research
IF3.4
2026-04-100
PRE
Kazunari Tanaka; Kunihiko Tsuji; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Fujimasa Tada; Hideko Ohama; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-Life Practice Experts for HCC (RELPEC) Study Group and Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group
Comparative diagnostic performance of ultrasound-guided attenuation parameter versus B-mode scoring for hepatic steatosis assessment: an ordinal-scale statistical approach

超声引导下衰减参数与B模式评分对肝脂肪变评估的对比诊断性能：一种序数尺度统计方法

Journal of Gastroenterology
IF5.5
2026-04-020
PRE
Takashi Kumada; Hidenori Toyoda; Sadanobu Ogawa; Tatsuya Gotoh; Yasuaki Suzuki; Kento Imajo; Masato Yoneda; Katsutoshi Sugimoto; Hidekatsu Kuroda; Nobuharu Tamaki; Masayuki Kurosaki; Tomoyuki Akita; Junko Tanaka; Atsushi Nakajima
Lymphocyte–Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab

淋巴细胞-单核细胞比值预测接受度鲁单单抗联合曲美单抗治疗的HCC患者的生存情况

Liver International
IF5.2
2026-02-260
PRE
Tomomitsu Matono; Toshifumi Tada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Takanori Matsuura; Yoshihide Ueda; Soo Ki Kim; Hideko Ohama; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Shinya Fukunishi; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Jumpei Okamura; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the RELPEC Group and HCC 48 Group
Prognostic Value of an Early Response to Tolvaptan and Its Clinical Implications in Patients With Cirrhosis and Hepatic Edema: A Nationwide Multicenter Cohort Study

托伐普坦早期反应的预后价值及其在肝硬化伴肝性水肿患者中的临床意义：一项全国多中心队列研究

Hepatology Research
IF3.4
2026-02-070
OA
Kaori Koyano; Taeang Arai; Hidenori Toyoda; Keizo Kato; Joji Tani; Suguru Ogura; Tomomi Okubo; Korenobu Hayama; Norio Itokawa; Toshifumi Tada; Akito Nozaki; Atsushi Hiraoka; Kentaro Matsuura; Toru Ishikawa; Naoto Kawabe; Tsunamasa Watanabe; Koichi Takaguchi; Asahiro Morishita; Hironao Okubo; Motoh Iwasa; Hiroki Nishikawa; Yasuhito Tanaka; Masanori Atsukawa
Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: results of the DT-real study

在临床实践中，durvalumab联合或单药使用tremelimumab治疗肝细胞癌的可重复安全性及有效性：DT-real研究结果

JHEP Reports
IF7.5
2025-11-200
OAAI
Ciro Celsa; Tiziana Pressiani; Naoshi Nishida; Shadi Mohamad Chamseddine; Ashwini Arvind; Michael Li; Marta Fortuny; Najib Ben Khaled; Massimo Iavarone; Hidenori Toyoda; Ilario Giovanni Rapposelli; Andrea Casadei-Gardini; Caterina Vivaldi; Susanna Ulahannan; Haripriya Andanamala; Bernhard Scheiner; Matthias Pinter; Elena Orlandi; Claudia A.M. Fulgenzi; Giulia F. Manfredi
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease

日本过去二十年间肝细胞癌治疗结果的演变：早期病毒性疾病的改善

HEPATOLOGY RESEARCH
IF3.4
2025-11-010
OA
Kariyama, Kazuya; Nouso, Kazuhiro; Hiraoka, Atsushi; Tada, Fujimasa; Ohama, Hideko; Toyoda, Hidenori; Yasuda, Satoshi; Tada, Toshifumi; Tanaka, Kazunari; Tsuji, Kunihiko; Itobayashi, Ei; Tsutsui, Akemi; Takaguchi, Koichi; Imai, Michitaka; Ishikawa, Toru; Hatanaka, Takeshi; Kakizaki, Satoru; Naganuma, Atsushi; Ueda, Yoshihide; Matono, Tomomitsu; Tamai, Hideyuki; Okamura, Junpei; Tanaka, Hironori; Yata, Yutaka; Wakuta, Akiko; Kudo, Masatoshi; Kumada, Takashi

研究方向

暂未获取到该数据
T
Takashi Kumada
H 指数:70论文数:719被引数:2.1万
T
Toshifumi Tada
H 指数:54论文数:455被引数:1.3万
A
Atsushi Hiraoka
H 指数:49论文数:543被引数:1.0万
S
Satoshi Yasuda
H 指数:32论文数:191被引数:3,747
T
Toru Ishikawa
H 指数:46论文数:522被引数:7,879
M
Masanori Atsukawa
H 指数:39论文数:354被引数:5,536
K
Koichi Takaguchi
H 指数:43论文数:254被引数:6,825
E
Ei Itobayashi
H 指数:35论文数:210被引数:3,681
K
Kazuya Kariyama
H 指数:37论文数:210被引数:4,724
K
Kazuhiro Nouso
H 指数:51论文数:417被引数:9,170